Introduction
Pressure ulcers are treated with a combination of pressure relief, wound care, infection control, nutritional support, and, in more advanced cases, surgical repair. These treatments are designed to address the biological processes that cause tissue injury when prolonged pressure reduces blood flow, deprives cells of oxygen and nutrients, and triggers local inflammation and tissue death. The overall aim is to restore circulation to damaged tissue, remove barriers to healing, prevent infection, and support the body’s normal repair mechanisms.
The treatment strategy depends on how deep the ulcer is, whether surrounding tissue is inflamed or infected, and whether the patient has ongoing factors that impair healing, such as immobility, poor nutrition, or vascular disease. In mild cases, reducing pressure and protecting the skin may allow the tissue to recover. In more severe cases, treatment must also remove dead tissue, manage bacterial burden, and sometimes replace destroyed tissue with surgical reconstruction.
Understanding the Treatment Goals
The main goal of treatment is to stop the cycle of ischemia and tissue breakdown. Pressure applied over a bony prominence compresses small blood vessels, reducing perfusion to the skin and deeper tissues. When this persists, cells cannot maintain normal metabolism, waste products accumulate, and tissue becomes inflamed and necrotic. Treatment is therefore directed at reversing or limiting these conditions.
A second goal is to reduce symptoms such as pain, drainage, odor, and local inflammation. These symptoms reflect active tissue injury, bacterial overgrowth, and exposure of nerve endings in the wound bed. By protecting the wound and controlling infection, treatment lowers the inflammatory burden and makes the tissue environment more favorable for repair.
Another major objective is to prevent progression. A superficial pressure injury can deepen if pressure continues or if devitalized tissue and moisture persist. Treatment decisions are guided by the need to interrupt this progression before subcutaneous fat, muscle, tendon, or bone are involved. In advanced ulcers, the goal extends to restoring function and preventing complications such as cellulitis, osteomyelitis, sepsis, and chronic nonhealing wounds.
Common Medical Treatments
Pressure redistribution is the foundational treatment. This includes repositioning, specialized mattresses, cushions, and support surfaces that redistribute load away from vulnerable areas. Biologically, these measures improve capillary blood flow by lowering the external pressure that compresses tissue. Once perfusion improves, oxygen delivery resumes, cellular metabolism can recover, and the wound has a better chance to granulate and epithelialize.
Wound cleansing is used to remove debris, exudate, and surface bacteria. Irrigation with appropriate solutions reduces the local concentration of inflammatory mediators and microorganisms that interfere with healing. A cleaner wound bed allows fibroblasts, keratinocytes, and immune cells to function more effectively. Cleansing also helps clinicians assess the depth and condition of the ulcer more accurately.
Debridement removes dead, necrotic, or nonviable tissue. This may be done surgically, mechanically, enzymatically, autolytically, or by other clinical methods. Necrotic tissue acts as a physical barrier to new tissue formation and can support bacterial growth. By removing this tissue, debridement lowers microbial burden, reduces inflammation, and exposes viable tissue capable of repairing the defect. It also improves oxygen diffusion into the wound bed, which is essential for collagen synthesis and angiogenesis.
Dressings are selected to maintain a moist but not overly wet wound environment. Moisture balance matters because epithelial cells migrate more effectively across a hydrated surface, while excessive fluid leads to maceration of surrounding skin and increased tissue fragility. Different dressings absorb exudate, protect the ulcer from contamination, or support autolytic debridement. Their function is not simply to cover the wound but to regulate the local microenvironment so healing cells can work efficiently.
Topical antimicrobials or antiseptics may be used when bacterial load is contributing to delayed healing. These agents reduce the number of microorganisms on the wound surface and within superficial tissue layers. Their effect is to limit the inflammatory response triggered by colonization or local infection, though they do not replace systemic therapy when deeper infection is present.
Systemic antibiotics are used when infection extends beyond the wound surface or when there are signs of cellulitis, osteomyelitis, or systemic involvement. Antibiotics reduce bacterial replication and help the host immune system control invasive organisms. In pressure ulcers complicated by bone infection, antibiotic therapy targets organisms within deeper tissues where local wound care alone is insufficient.
Pain control is also part of medical management. Pain reflects nerve irritation, inflammation, and exposure of sensitive tissue. Analgesics reduce nociceptive signaling and can make ongoing wound care possible, especially when dressing changes or debridement would otherwise intensify discomfort. Controlling pain also reduces stress responses that can interfere with sleep, nutrition, and overall recovery.
Nutritional support is commonly included because tissue repair requires protein, calories, zinc, vitamin C, iron, and adequate hydration. Protein provides amino acids for collagen, immune proteins, and new cell growth. Calories prevent the body from breaking down lean tissue for energy. Without sufficient substrate, fibroblast activity, immune defense, and collagen deposition are impaired, and the ulcer is less likely to close.
Procedures or Interventions
Some pressure ulcers require procedural treatment when conservative measures are not enough. Surgical debridement is used for extensive necrosis, slough, abscess, or tissue that cannot be removed safely by less invasive means. This procedure rapidly eliminates dead tissue that would otherwise maintain inflammation and harbor bacteria. It can also expose deeper structures so the extent of the injury becomes clear.
Negative pressure wound therapy may be used in selected ulcers after debridement. This technique applies controlled suction through a sealed dressing. The negative pressure removes excess exudate, decreases local edema, and can improve microcirculation in the wound bed. By reducing tissue swelling, it increases perfusion gradients and helps draw wound edges together. It also promotes formation of granulation tissue, which is the vascular connective tissue needed for closure or grafting.
Skin grafting and flap reconstruction are considered for large, deep, or chronic ulcers, especially when bone or tendon is exposed. A graft provides epithelial coverage, while a flap brings in vascularized tissue that can fill dead space and improve local blood supply. These procedures change the physical structure of the area by replacing tissue that cannot heal on its own with living tissue that has better perfusion and greater resistance to breakdown.
Drainage of abscesses or treatment of osteomyelitis may also be needed. If pus has accumulated, drainage lowers pressure within the infected space and removes material that sustains bacterial growth. When bone infection is present, treatment may require prolonged antibiotics and sometimes surgical removal of infected bone, because avascular or necrotic bone is difficult for immune cells and medications to penetrate.
Supportive or Long-Term Management Approaches
Long-term control focuses on preventing the conditions that allowed the ulcer to form. Regular pressure relief remains essential because even a healing wound can reopen if tissue is repeatedly compressed. Support surfaces, frequent repositioning, and reduction of friction and shear decrease mechanical stress on skin and deeper soft tissue. These measures protect the microcirculation and prevent renewed ischemia.
Ongoing skin inspection and wound monitoring help track changes in size, depth, drainage, odor, and the condition of the wound edges. This surveillance identifies delayed healing, infection, or worsening tissue viability before they become severe. Monitoring matters because pressure ulcers often evolve gradually, and the underlying pathophysiology can change as granulation tissue forms or as bacterial burden increases.
Management of chronic illnesses also influences healing. Conditions such as diabetes, peripheral arterial disease, anemia, and malnutrition reduce oxygen delivery or impair immune and reparative function. When these problems are addressed, the wound environment becomes more favorable for angiogenesis, collagen deposition, and epithelial migration. Even when the ulcer is locally treated, uncontrolled systemic illness can keep the tissue in a state of impaired repair.
Maintaining moisture balance, managing incontinence, and protecting skin from prolonged exposure to urine or stool are also part of long-term care. Excess moisture weakens the outer skin barrier and increases the risk of breakdown through maceration and enzyme-mediated injury. Reducing exposure preserves epidermal integrity and prevents new ulcers from forming around the existing wound.
Factors That Influence Treatment Choices
Treatment varies with the stage and depth of the ulcer. A stage 1 pressure injury may respond to pressure relief and skin protection because the tissue is still intact and the damage is largely reversible. A stage 3 or 4 ulcer has full-thickness tissue loss, often with necrosis or exposed deeper structures, and therefore requires debridement, advanced dressings, infection assessment, and sometimes surgery.
The presence of infection strongly affects management. A clean, noninfected ulcer can often be managed with local wound care and offloading, whereas an infected ulcer may need cultures, systemic antibiotics, or operative drainage. Infection increases metabolic demand and inflammatory injury, making tissue repair less efficient.
Age, mobility, and overall health shape treatment decisions because they influence circulation, immune response, and the ability to reposition. Older adults and patients with neurologic impairment, frailty, or poor perfusion may heal more slowly and may not tolerate aggressive procedures. In such cases, treatment may emphasize comfort, protection, and control of progression rather than rapid reconstruction.
Associated medical conditions such as diabetes, vascular disease, renal failure, or malnutrition change the tissue environment in ways that impair oxygen delivery, immune function, or collagen formation. These conditions can limit the effectiveness of standard therapies and increase the need for coordinated medical management.
Response to prior treatment also matters. If a wound decreases in size and develops healthy granulation tissue, conservative care may continue. If it stagnates, becomes more necrotic, or develops recurrent infection, escalation to debridement, advanced dressings, negative pressure therapy, or surgery is often considered because the biology of the wound has not shifted toward healing.
Potential Risks or Limitations of Treatment
Pressure relief and repositioning can be limited by patient frailty, pain, spasticity, or inability to maintain consistent offloading. If pressure is not adequately reduced, the same vascular compression that caused the ulcer continues to impede tissue recovery.
Debridement has benefits but also risks. Removing tissue can cause bleeding, pain, and temporary enlargement of the wound surface. In poorly perfused tissue, aggressive debridement may expose areas that cannot heal quickly, and if infection or ischemia is extensive, the wound may remain open despite treatment.
Topical antimicrobials and systemic antibiotics can reduce bacterial burden, but they do not reverse tissue death or poor perfusion. Overuse of antimicrobials may also alter normal microbial flora or select for resistant organisms. Antibiotics can cause adverse effects and may not penetrate well into avascular tissue or infected bone.
Negative pressure wound therapy is not suitable for every wound. It can worsen bleeding in some settings, may be difficult to seal over irregular body surfaces, and can cause discomfort. Surgical reconstruction carries risks related to anesthesia, poor graft or flap survival, wound dehiscence, and recurrence if the underlying pressure problem is not corrected. These limitations reflect the fact that treatment can improve local tissue biology, but cannot fully overcome ongoing mechanical stress or severe systemic disease without broader management.
Conclusion
Pressure ulcers are treated by correcting the mechanical and biological conditions that prevent tissue survival and repair. The central approach is to remove pressure and restore perfusion, because sustained compression is the primary driver of ischemic injury. Wound cleansing, debridement, dressings, infection control, nutritional support, and pain management work by improving the wound environment so cells involved in repair can function normally. Advanced procedures such as negative pressure therapy, grafting, and flap reconstruction are used when tissue loss is too extensive for conservative healing alone.
Effective treatment is therefore not limited to covering the wound. It is aimed at reversing local ischemia, reducing inflammation, removing devitalized tissue, limiting infection, and supporting regeneration. The choice of therapy depends on ulcer stage, depth, infection status, and the patient’s overall condition, because these factors determine how much the underlying tissue injury can be corrected and how much help the wound will need to heal.